Pharmaceutical composition for treating alcohol-induced liver damage comprising (4S,5S)-5-fluoromethyl-5-hydroxy-4-({[( 5R)-5-isopropyl-3-(isoquinolin-1-yl)-4,5dihydro5-isoxazolyl]carbonyl}amino)-dihydrofur an-2-one or pharmaceutically acceptable salt thereof

Details for Australian Patent Application No. 2008243206 (hide)

Owner LG Life Sciences Ltd.

Inventors Park, Jung Gyu; Oh, Yeong Soo; Park, Mi Jeong; Paik, Yong Han; Chang, Hye Kyung; Shin, Hyun Ik

Agent Spruson & Ferguson

Pub. Number AU-A-2008243206

Filing date 11 November 2008

Wipo publication date 27 May 2010

International Classifications

A61K 31/4725 (2006.01)

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

27 November 2008 Complete Application Filed

27 May 2010 Application Open to Public Inspection

  Published as AU-A-2008243206

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008243207-Vertebral support rod implantation kit and method

2008243205-Speeding cure rate of bioadhesives